1103929-51-6

Basic information

• Product Name: [(2-{[4-chloro-2-(methoxycarbonyl)phenyl]amino}-2-oxoethyl)(methyl)amino]acetic acid
• Synonyms: [(2-{[4-chloro-2-(methoxycarbonyl)phenyl]amino}-2-oxoethyl)(methyl)amino]acetic acid
• CAS NO: 1103929-51-6
• Molecular Weight: 314.726
• Mol File: 1103929-51-6.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: [(2-{[4-chloro-2-(methoxycarbonyl)phenyl]amino}-2-oxoethyl)(methyl)amino]acetic acid(CAS DataBase Reference)
• NIST Chemistry Reference: [(2-{[4-chloro-2-(methoxycarbonyl)phenyl]amino}-2-oxoethyl)(methyl)amino]acetic acid(1103929-51-6)
• EPA Substance Registry System: [(2-{[4-chloro-2-(methoxycarbonyl)phenyl]amino}-2-oxoethyl)(methyl)amino]acetic acid(1103929-51-6)

Safety Data

• Hazardous Substances Data: 1103929-51-6(Hazardous Substances Data)

Upstream product

• 4408-64-4 N-methyliminodiacetic acid 
• 5202-89-1 4-chlorobenzenesulfonyl chloride 

Relevant articles and documents

Structure-activity relationships of new N-acylanthranilic acid derivatives as plasminogen activator inhibitor-1 inhibitors

Novel anthranilic acid derivatives having substituted N-acyl side chains were designed and synthesized for evaluation as plasminogen activator inhibitor-1 (PAI-1) inhibitors. Compounds with a 4-diphenylmethyl-1-piperazinyl moiety on the acyl side chains in general exhibited potent in vitro PAI-1 inhibitory activity and good pharmacokinetic profiles after oral administration in rats. Compound 16f (TM5275) was identified as a promising candidate for further pharmacological evaluation.